Report: No “Death Spiral” for ACA
An analysis from Standard & Poor’s found that the Affordable Care Act (ACA) may be healthier than previously thought. According to The New York Times, the report found that not only are insurers likely to break even this year, but most could see small profits in 2018. There are now signs that the market will be manageable for most insurers and is not in a so-called “death spiral.” This news came the same week that Wellmark Blue Cross and Blue Shield and Aetna said they would exit the Iowa exchange.
Minnesota Scraps State ACA Exchange
 Minnesota will move to the federally run health insurance exchange on January 1, 2019. A bill that passed the House would get rid of the state-run exchange, MNsure, which enrolled more than 100,000 Minnesotans this year, reported Post-Bulletin. With Minnesota moving to the federal exchange, there will only be 10 states and the District of Columbia still operating state-run exchanges under the ACA.
Curtailing Direct-to-Consumer Drug Ads
 America is one of just 2 developed countries that allow TV ads for prescription drugs, but that may change. According to STAT, Democrats want to make it less economically viable for companies to advertise directly to consumers, and Republicans may join the cause. The proposal being considered would force drug companies to pay taxes on advertising expenses–currently, they can write off those expenses.
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Polatuzumab Vedotin and R-CHP Appropriate for Untreated DLBCL
April 24th 2024Population pharmacokinetic and exposure-response analyses revealed a favorable benefit-risk profilane for the treatment combination of polatuzumab vedotin and rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP).
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More